ABCG2 promoter hypomethylation has been observed in MDR cell line models of ALL leukemia, ovarian carcinoma, and a stem-like cell subpopulation of prostate carcinoma. The gene discussed is ABCG2; the disease is acute lymphoblastic leukemia.